China (Mainland)
ADP Na2 CAS 16178-48-6 Adenosine-5'-diphosphate disodium salt CAS NO.16178-48-6
- FOB Price: USD: 200.00-200.00 /Kilogram Get Latest Price
- Min.Order: 25 Kilogram
- Payment Terms: T/T,Other
- Available Specifications:
Medical grade(25-50)Kilogram
- Product Details
Keywords
- ADP
- Adenosine-5'-diphosphate disodium salt
- 16178-48-6
Quick Details
- ProName: ADP Na2 CAS 16178-48-6 Adenosine-5'-di...
- CasNo: 16178-48-6
- Molecular Formula: C10H13N5Na2O10P2
- Appearance: White powder
- Application: Nucleoside
- DeliveryTime: within one week
- PackAge: 25kgs/drum paper-drums and two plastic...
- Port: Shanghai
- ProductionCapacity: 2000 Kilogram/Day
- Purity: ≥99.0%
- Storage: Store in tight containers, in a cool d...
- Transportation: Express(DHL/FedEx/TNT),AIR,SEA
- LimitNum: 25 Kilogram
- Moisture Content: <0.2%
- Impurity: <0.10%
Superiority
Trade Assurance
Get full protection for your orders
100% Product quality protection
100% On-time shipment protection
100% Payment protection
Details
【Product name】 Adenosine-5'-diphosphate disodium salt
【Synonyms】ADP-Na2; 5'-ADP-Na2
【CAS NO.】16178-48-6
【Mol. Formula】C10H13N5Na2O10P2
【Mol. Weight】471.16
【Assay】95%min
【Appearance】White powder
【Standard】Medicine grade, Tech. grade
【Packing】25kgs/drum (standard packing)
【Storage】Tight container, protect from light
Disodium adenosine diphosphate is ADP. It is the earliest discovered and the most important platelet aggregation inducing substance in the body. It exists in the high-density particles in the blood cells, and is released when the platelet coagulates. ADP affects the shape and biological behavior of platelets through ADP receptors on platelets, and further accelerates the aggregation process of platelets. It is generally used in biochemical research, determination of pyruvate kinase activity, preparation of polynucleotide and so on.
Quality standard
|
Items |
Specifications |
|
Description |
White powder |
|
Identification |
IR |
|
|
HPLC |
|
Heavy metal |
≤10ppm |
|
Pb |
≤3ppm |
|
Hg |
≤0.1ppm |
|
Cd |
≤1ppm |
|
Loss on drying |
≤0.5% |
|
Residue on lgnition |
≤0.1% |
|
Single impurity |
≤0.5% |
|
Total impurity |
≤1.0% |
|
Total bacteria |
≤1000cfu/g |
|
Yeast and Mould |
≤100 cfu/g |
|
E.coli/25g |
Absent |
|
Salmonella/25g |
Absent |
|
Assay |
≥99.0% |
Shanghai Soyoung Biotechnology Inc. a faithful and professional supplier and exporter of healthcare raw materials for pharmacy, nutrition and food industries for years with own laboratory and GMP standard factories.
Shanghai Soyoung has R&D Center and Testing Center, and has international advanced facilities of HPLC, GC, AAS, UV, TLC, LC-MS and IR equipments.
Shanghai Soyoung has nearly 20 years production experience, it is producing in GMP workshop, each batch pass strict testing before shipment. Strict quality control is performed in every procedure from material sourcing, processing and testing to packing.
|
Company name |
Shanghai Soyoung Biotechnology Inc. |
|
Main Products |
Health care ingredients |
|
Location |
Shanghai,China |
|
Business Type |
Manufacturer & Trader |
|
Year start exporting |
2011 |
|
Number of employees |
60-70 people |
|
Factory area |
18,000 square meters |
|
Total annual sales volume |
US$3,000,000-5,000,000 |
|
Main Markets |
America,Europe,Mid East,Asia,South Africa and etc. |
|
Certifications |
GMP,ISO,HACCP,Kosher |
Shanghai SOYOUNG onsite assessment conducted by Bureau Veritas commissioned at June 2018. Assessed Supplier of Shanghai SOYOUNG is a faithful and professional supplier of health raw materials in pharmacy, food, cosmetic and other fields for many years, with own laboratories and GMP standard factories.
1. 12 years specialized in health products field.
2. GMP/ISO certificated factories and stable supply chain.
3. Quality first, strictly control before shipments.
4. Custom synthesis by more than 20 professional chemists.
5. Small order,free sample and one step service available.
6. Rapid delivery, 1-6 business days from China warehouse.
7. Support 7 days refund money in case delay shipment.
8. Assessment conducted by Bureau Veritas at 2018.